Durso Danielle Fernandes, Bacalini Maria Giulia, do Valle Ítalo Faria, Pirazzini Chiara, Bonafé Massimiliano, Castellani Gastone, Faria Ana Maria Caetano, Franceschi Claudio, Garagnani Paolo, Nardini Christine
Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
National Counsel of Technological and Scientific Development (CNPq), ministry of science technology and innovation (MCTI), Brasilia, Brazil.
Oncotarget. 2017 Feb 21;8(8):12820-12830. doi: 10.18632/oncotarget.14590.
Colorectal cancer is among the leading causes of cancer death worldwide. Despite numerous molecular characterizations of the phenomenon, the exact dynamics of its onset and progression remain elusive. Colorectal cancer onset has been characterized by changes in DNA methylation profiles, that, owing to the stability of their patterns, are promising candidates to shed light on the molecular events laying at the base of this phenomenon.To exploit this stability and reinforce it, we conducted a meta-analysis on publicly available DNA methylation datasets generated on: normal colorectal, adenoma (ADE) and adenocarcinoma (CRC) samples using the Illumina 450k array, in the systems medicine frame, searching for tumor gene episignatures, to produce a carefully selected list of potential drivers, markers and targets of the disease. The analysis proceeds from a differential meta-analysis of the methylation profiles using an analytical pipeline recently developed by our group [1], through network reconstruction, topological and functional analyses, to finally highlight relevant epigenomic features. Our results show that genes already highlighted for their genetic or transcriptional alteration in colorectal cancer are also differentially methylated, reinforcing -regardless of the level of cellular control- their role in the complex of alterations involved in tumorigenesis.These findings were finally validated in an independent cohort from The Cancer Genome Atlas (TCGA).
结直肠癌是全球癌症死亡的主要原因之一。尽管对该现象进行了大量分子特征研究,但其确切的发病和进展动态仍不清楚。结直肠癌的发病特征是DNA甲基化谱的变化,由于其模式的稳定性,这些变化有望揭示这一现象背后的分子事件。为了利用这种稳定性并加强它,我们在系统医学框架下,对使用Illumina 450k阵列在正常结直肠、腺瘤(ADE)和腺癌(CRC)样本上生成的公开可用DNA甲基化数据集进行了荟萃分析,寻找肿瘤基因表观特征,以生成一份精心挑选的该疾病潜在驱动因素、标志物和靶点清单。该分析从使用我们小组最近开发的分析流程[1]对甲基化谱进行差异荟萃分析开始,经过网络重建、拓扑和功能分析,最终突出相关的表观基因组特征。我们的结果表明,在结直肠癌中因遗传或转录改变而已经被突出的基因也存在差异甲基化,这强化了它们在肿瘤发生所涉及的复杂改变中的作用,而不论细胞控制水平如何。这些发现最终在来自癌症基因组图谱(TCGA)的一个独立队列中得到了验证。